Bank Ozk (OZK) Given Consensus Rating of “Hold” by Brokerages

Share on StockTwits

Shares of Bank Ozk (NASDAQ:OZK) have earned an average rating of “Hold” from the thirteen brokerages that are presently covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $29.75.

Several research analysts have weighed in on the company. Piper Jaffray Companies downgraded Bank Ozk from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $52.00 to $31.00 in a research note on Tuesday. Stephens reiterated a “hold” rating and issued a $28.00 target price on shares of Bank Ozk in a research note on Friday, November 9th. Brean Capital reiterated a “buy” rating on shares of Bank Ozk in a research note on Monday, October 29th. UBS Group upgraded Bank Ozk from a “sell” rating to a “neutral” rating and lowered their target price for the company from $36.00 to $27.00 in a research note on Wednesday, October 24th. They noted that the move was a valuation call. Finally, Citigroup lowered their target price on Bank Ozk from $59.00 to $31.00 and set a “buy” rating on the stock in a research note on Monday, October 22nd.

NASDAQ:OZK traded down $0.57 during mid-day trading on Monday, reaching $23.79. 1,149,671 shares of the stock were exchanged, compared to its average volume of 1,249,392. The company has a market capitalization of $3.12 billion, a PE ratio of 8.04, a P/E/G ratio of 0.64 and a beta of 1.46. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.09. Bank Ozk has a 1 year low of $23.35 and a 1 year high of $53.70.

Bank Ozk (NASDAQ:OZK) last announced its earnings results on Thursday, October 18th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.90 by ($0.32). Bank Ozk had a net margin of 38.37% and a return on equity of 11.17%. The company had revenue of $244.74 million during the quarter, compared to analysts’ expectations of $258.05 million. During the same quarter last year, the business posted $0.75 earnings per share. As a group, sell-side analysts anticipate that Bank Ozk will post 3.18 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Panagora Asset Management Inc. lifted its holdings in shares of Bank Ozk by 51.4% in the 3rd quarter. Panagora Asset Management Inc. now owns 6,040 shares of the company’s stock valued at $229,000 after buying an additional 2,050 shares during the period. Benjamin F. Edwards & Company Inc. acquired a new stake in shares of Bank Ozk in the 3rd quarter valued at approximately $120,000. Paradigm Asset Management Co. LLC acquired a new stake in shares of Bank Ozk in the 3rd quarter valued at approximately $121,000. Twin Tree Management LP acquired a new stake in shares of Bank Ozk in the 3rd quarter valued at approximately $141,000. Finally, Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of Bank Ozk in the 3rd quarter valued at approximately $199,000. 88.14% of the stock is owned by institutional investors and hedge funds.

Bank Ozk Company Profile

Bank OZK provides a range of retail and commercial banking services to businesses, individuals, and non-profit and governmental entities. The company accepts non-interest bearing checking, interest bearing transaction, business sweep, savings, money market, individual retirement, and other accounts, as well as time deposits.

Featured Article: Stock Split

Analyst Recommendations for Bank Ozk (NASDAQ:OZK)

Receive News & Ratings for Bank Ozk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bank Ozk and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.